United States · FDA National Drug Code directory
ESOMEPRAZOLE MAGNESIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-880_cd6b21e6-4d3f-40b5-89ee-52a1c83d8700
- Product NDC
- 16571-880
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- ESOMEPRAZOLE MAGNESIUM
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221201
- Source listing expiry
- 20261231
Source-listed ingredients
- ESOMEPRAZOLE MAGNESIUM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (16571-880-41) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 16571-880-41
- 3 BOTTLE in 1 CARTON (16571-880-42) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE · 16571-880-42
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →